Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | Euronext Growth Oslo |
Sektor | Hälsovård |
Industri | Medicinteknik |
2021-12-17 14:39:47
Notice is hereby given of an extraordinary general meeting of SoftOx Solutions
AS (the "Company") to be held on the 29 December 2021 at 10:00.
Pursuant to section 5-8 of the Norwegian Private Limited Liability Companies Act
and due to the ongoing COVID-19 pandemic, the extraordinary general meeting will
be held as a video conference meeting without physical attendance for the
shareholders. Shareholders who wish to participate electronically must send a
notice of attendance to the Company by 28 December 2021 at 12:00 in accordance
with the attached notice of attendance form. Details for the video conference
meeting will only be provided to shareholders who have given notice in advance.
For further information, please contact:
CEO Geir Almås of SoftOx Solutions AS, or
CFO Kristine Mundal Rød of SoftOx Solutions AS
Mail: ir@soft-ox.com
Mobile: (+47) 948 59 599
About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian
BioTech company based in Oslo with the aim of helping to combat major threats to
human health, namely the emergence of antimicrobial resistance (AMR), biofilm
infections in chronic wounds and the spread of viruses. For more information on
SoftOx, visit www.soft-ox.com